Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma
Disease area: Airway diseases, Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. van Berkel, C. Robroeks, J. Dallinga, Q. Jobsis, E. Moonen, E. Wouters, F. J. van Schooten, E. Dompeling (Maastricht, Horn, Netherlands). Volatile organic compounds in exhaled breath are associated with exacerbations in children with asthma. Eur Respir J 2009; 34: Suppl. 53, 1194

Member's Comments

No comment yet.

Related content which might interest you: Volatile organic compounds in exhaled breath in preschool children with and without recurrent wheeze Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma Year: 2009 Volatile organic compounds (VOC) in exhaled breath of patients with COPD Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases Year: 2010 Exhaled breath profiling in diagnosing wheezy preschool children Source: Eur Respir J 2013; 41: 183-188 Year: 2013 Analysis of semi-volatile organic compounds in exhaled breath condensate of patients with obstructive lung diseases Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010 Semi-volatile organic compounds in exhaled breath condensate: a new approach in the differential diagnosis of asthma and COPD Source: Annual Congress 2009 - Asthma assessment and original therapeutic approaches Year: 2009 Exhaled volatile organic compounds as markers for medication use in asthma Source: Eur Respir J, 55 (2) 1900544; 10.1183/13993003.00544-2019 Year: 2020 Exhaled air volatile organic compounds and eosinophilic airway inflammation in asthma Source: Annual Congress 2012 - Clinical diagnosis and treatment of adult asthma Year: 2012 Leukotrienes in exhaled breath condensate of children with asthma Source: Eur Respir J 2001; 18: Suppl. 33, 39s Year: 2001 Exhaled volatile organic compounds differentiate between children with atopic asthma and healthy controls Source: Annual Congress 2009 - Paediatric lung function, imaging and methodology in health and disease Year: 2009 Limited clinical value of exhaled volatile organic compound measurements in childhood asthma Source: ERJ Open Res, 4 (4) 00026-2018; 10.1183/23120541.00026-2018 Year: 2018 Exhaled volatile organic compounds predict exacerbations of childhood asthma in a 1-year prospective study Source: Eur Respir J 2013; 42: 98-106 Year: 2013 Leukotrienes in exhaled breath condensate in childhood asthma Source: Eur Respir J 2003; 22: Suppl. 45, 398s Year: 2003 Can exhaled volatile organic compounds predict asthma exacerbations in children? Source: International Congress 2015 – Phenotyping asthma with biomarkers Year: 2015 Value of exhaled volatile organic compounds in monitoring airway disease Source: School Course 2013 - Monitoring of asthma, COPD and other airway diseases Year: 2013 Volatile organic compounds (VOCs) in COPD patients with exacerbation Source: Annual Congress 2011 - Role of the biomarkers in airway diseases Year: 2011 Prediction of asthma exacerbations in children by FeNO and non-invasive inflammatory markers in exhaled breath condensate Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children Year: 2008